NBIX
Neurocrine Biosciences·NASDAQ
--
--(--)
--
--(--)
3.76 / 10
Netural
NBIX's fundamental status is lackluster with a 3.8/10 score. Key weaknesses include a high PB-ROE value of 2.2098, indicating potential overvaluation relative to peers, while moderate YoY revenue growth of 18.95% and a solid interest-coverage ratio of 15.48 offer some support. Days sales outstanding at 79.2985 suggest slower receivable collection, offsetting otherwise healthy liquidity. Overall, the fundamental picture calls for cautious positioning.
Analysis Checks(9/10)
Revenue-MV
Value-0.52
Score3/3
Weight20.96%
1M Return10.54%
Value-0.52
Score3/3
Weight20.96%
1M Return10.54%
Days sales outstanding
Value79.30
Score2/3
Weight1.82%
1M Return1.10%
Value79.30
Score2/3
Weight1.82%
1M Return1.10%
Net income-Revenue
Value0.76
Score2/3
Weight16.73%
1M Return8.45%
Value0.76
Score2/3
Weight16.73%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.67%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.67%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight21.55%
1M Return10.15%
Value-0.50
Score2/3
Weight21.55%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value18.95
Score2/3
Weight1.79%
1M Return1.11%
Value18.95
Score2/3
Weight1.79%
1M Return1.11%
Profit-MV
Value0.22
Score2/3
Weight16.71%
1M Return8.45%
Value0.22
Score2/3
Weight16.71%
1M Return8.45%
PB-ROE
Value2.21
Score0/3
Weight4.99%
1M Return2.72%
Value2.21
Score0/3
Weight4.99%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value18.95
Score2/3
Weight0.69%
1M Return0.43%
Value18.95
Score2/3
Weight0.69%
1M Return0.43%
Cash-MV
Value-0.27
Score2/3
Weight16.43%
1M Return8.41%
Value-0.27
Score2/3
Weight16.43%
1M Return8.41%
Revenue-MV
Value-0.52
Score3/3
Weight20.96%
1M Return10.54%
Value-0.52
Score3/3
Weight20.96%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value18.95
Score2/3
Weight1.79%
1M Return1.11%
Value18.95
Score2/3
Weight1.79%
1M Return1.11%
Days sales outstanding
Value79.30
Score2/3
Weight1.82%
1M Return1.10%
Value79.30
Score2/3
Weight1.82%
1M Return1.10%
Profit-MV
Value0.22
Score2/3
Weight16.71%
1M Return8.45%
Value0.22
Score2/3
Weight16.71%
1M Return8.45%
Net income-Revenue
Value0.76
Score2/3
Weight16.73%
1M Return8.45%
Value0.76
Score2/3
Weight16.73%
1M Return8.45%
PB-ROE
Value2.21
Score0/3
Weight4.99%
1M Return2.72%
Value2.21
Score0/3
Weight4.99%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.67%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.67%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value18.95
Score2/3
Weight0.69%
1M Return0.43%
Value18.95
Score2/3
Weight0.69%
1M Return0.43%
Asset-MV
Value-0.50
Score2/3
Weight21.55%
1M Return10.15%
Value-0.50
Score2/3
Weight21.55%
1M Return10.15%
Cash-MV
Value-0.27
Score2/3
Weight16.43%
1M Return8.41%
Value-0.27
Score2/3
Weight16.43%
1M Return8.41%
Is NBIX undervalued or overvalued?
- NBIX scores 3.76/10 on fundamentals and holds a Fair valuation at present. Backed by its 11.62% ROE, 15.95% net margin, 32.89 P/E ratio, 4.69 P/B ratio, and 10.82% earnings growth, these metrics solidify its Netural investment rating.
